Amyloid precursor protein and amyloid precursor-like protein 2 in cancer

Amyloid precursor protein (APP) and its family members amyloid precursor-like protein 1 (APLP1) and amyloid precursor-like protein 2 (APLP2) are type 1 transmembrane glycoproteins that are highly conserved across species. The transcriptional regulation of APP and APLP2 is similar but not identical,...

Descripción completa

Detalles Bibliográficos
Autores principales: Pandey, Poomy, Sliker, Bailee, Peters, Haley L., Tuli, Amit, Herskovitz, Jonathan, Smits, Kaitlin, Purohit, Abhilasha, Singh, Rakesh K., Dong, Jixin, Batra, Surinder K., Coulter, Donald W., Solheim, Joyce C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4991393/
https://www.ncbi.nlm.nih.gov/pubmed/26840089
http://dx.doi.org/10.18632/oncotarget.7103
Descripción
Sumario:Amyloid precursor protein (APP) and its family members amyloid precursor-like protein 1 (APLP1) and amyloid precursor-like protein 2 (APLP2) are type 1 transmembrane glycoproteins that are highly conserved across species. The transcriptional regulation of APP and APLP2 is similar but not identical, and the cleavage of both proteins is regulated by phosphorylation. APP has been implicated in Alzheimer's disease causation, and in addition to its importance in neurology, APP is deregulated in cancer cells. APLP2 is likewise overexpressed in cancer cells, and APLP2 and APP are linked to increased tumor cell proliferation, migration, and invasion. In this present review, we discuss the unfolding account of these APP family members’ roles in cancer progression and metastasis.

Ejemplares similares